Roles of Human CYP2A6 and Monkey CYP2A24 and 2A26 Cytochrome P450 Enzymes in the Oxidation of 2,5,29,59-Tetrachlorobiphenyl

被引:25
|
作者
Shimada, Tsutomu [1 ]
Kakimoto, Kensaku [2 ]
Takenaka, Shigeo [1 ]
Koga, Nobuyuki [3 ]
Uehara, Shotaro [4 ]
Murayama, Norie [4 ]
Yamazaki, Hiroshi [4 ]
Kim, Donghak [5 ]
Guengerich, F. Peter [6 ]
Komori, Masayuki [1 ]
机构
[1] Osaka Prefecture Univ, Lab Cellular & Mol Biol, Izumisano, Osaka, Japan
[2] Osaka Prefectural Inst Publ Hlth, Higashinari Ku, Osaka, Japan
[3] Nakamura Gakuen Univ, Fac Nutr Sci, Johnan Ku, Fukuoka, Japan
[4] Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Machida, Tokyo, Japan
[5] Konkuk Univ, Dept Biol Sci, Seoul, South Korea
[6] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37235 USA
基金
日本学术振兴会;
关键词
CONGENER-SPECIFIC ANALYSIS; RAT-LIVER MICROSOMES; POLYCHLORINATED-BIPHENYLS; ESCHERICHIA-COLI; NADPH-P450; REDUCTASE; CATALYTIC-ACTIVITIES; HEPATIC MICROSOMES; CYNOMOLGUS MONKEYS; HAMSTER LIVER; AMINO-ACID;
D O I
10.1124/dmd.116.072991
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
2,5,2',5'-Tetrachlorobiphenyl (TCB) induced type I binding spectra with cytochrome P450 (P450) 2A6 and 2A13, with Ks values of 9.4 and 0.51 mM, respectively. However, CYP2A6 oxidized 2,5,2',5'-TCB to form 4-hydroxylated products at a much higher rate (similar to 1.0 minute(-1)) than CYP2A13 (similar to 0.02 minute(-1)) based on analysis by liquid chromatography-tandem mass spectrometry. Formation of 4-hydroxy-2,5,2',5'-TCB by CYP2A6 was greater than that of 3-hydroxy-2,5,2',5'-TCB and three other hydroxylated products. Several human P450 enzymes, including CYP1A1, 1A2, 1B1, 2B6, 2D6, 2E1, 2C9, and 3A4, did not show any detectable activities in oxidizing 2,5,2',5'-TCB. Cynomolgus monkey CYP2A24, which shows 95% amino acid identity to human CYP2A6, catalyzed 4-hydroxylation of 2,5,2',5'-TCB at a higher rate (similar to 0.3 minute(-1)) than CYP2A26 (93% identity to CYP2A6, similar to 0.13 minute(-1)) and CYP2A23 (94% identity to CYP2A13, similar to 0.008 minute(-1)). None of these human and monkey CYP2A enzymes were catalytically active in oxidizing other TCB congeners, such as 2,4,3',4'-, 3,4,3',4'-, and 3,5,3',5'-TCB. Molecular docking analysis suggested that there are different orientations of interaction of 2,5,2',5'-TCB with the active sites (over the heme) of human and monkey CYP2A enzymes, and that ligand interaction energies (U values) of bound protein-ligand complexes show structural relationships of interaction of TCBs and other ligands with active sites of CYP2A enzymes. Catalytic differences in human and monkey CYP2A enzymes in the oxidation of 2,5,2',5'-TCB are suggested to be due to amino acid changes at substrate recognition sites, i.e., V110L, I209S, I300F, V365M, S369G, and R372H, based on the comparison of primary sequences.
引用
收藏
页码:1899 / 1909
页数:11
相关论文
共 50 条
  • [31] In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene
    Taavitsainen, P
    Juvonen, R
    Pelkonen, O
    DRUG METABOLISM AND DISPOSITION, 2001, 29 (03) : 217 - 222
  • [32] Variability in human drug metabolizing cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 activities caused by genetic variations in cytochrome P450 oxidoreductase
    Velazquez, Maria Natalia Rojas
    Parween, Shaheena
    Udhane, Sameer S.
    Pandey, Amit, V
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 515 (01) : 133 - 138
  • [33] EXPRESSION OF THE CYTOCHROME P450 EPOXYGENASE CYP2J2 IN HUMAN MONOCYTIC LEUKOCYTES
    Nakayama, Kaeko
    Nitto, Takeaki
    Inoue, Teruo
    Node, Koichi
    JOURNAL OF VASCULAR RESEARCH, 2009, 46 : 199 - 199
  • [34] Expression of the cytochrome P450 epoxygenase CYP2J2 in human monocytic leukocytes
    Nakayama, Kaeko
    Nitto, Takeaki
    Inoue, Teruo
    Node, Koichi
    LIFE SCIENCES, 2008, 83 (9-10) : 339 - 345
  • [35] Interaction of delavirdine with human liver microsomal cytochrome P450: Inhibition of CYP2C9, CYP2C19, and CYP2D6
    Voorman, RL
    Payne, NA
    Wienkers, LC
    Hauer, MJ
    Sanders, PE
    DRUG METABOLISM AND DISPOSITION, 2001, 29 (01) : 41 - 47
  • [36] Effect of antifungal drugs on cytochrome P450 (CYP) 1A2, CYP2D6, and CYP2E1 activities in human liver microsomes
    Niwa, T
    Inoue-Yamamoto, S
    Shiraga, T
    Takagi, A
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (09) : 1813 - 1816
  • [37] Genetic polymorphism of cytochrome P450 enzymes in asian populations: Focus on CYP2D6
    Kitada, M
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 2003, 23 (01) : 31 - 35
  • [38] Oxidation of 1-chloropyrene by human CYP1 family and CYP2A subfamily cytochrome P450 enzymes: catalytic roles of two CYP1B1 and five CYP2A13 allelic variants
    Shimada, Tsutomu
    Murayama, Norie
    Kakimoto, Kensaku
    Takenaka, Shigeo
    Lim, Young-Ran
    Yeom, Sora
    Kim, Donghak
    Yamazaki, Hiroshi
    Guengerich, F. Peter
    Komori, Masayuki
    XENOBIOTICA, 2018, 48 (06) : 565 - 575
  • [39] SIMULTANEOUS ACTION OF THE FLAVONOID QUERCETIN ON CYTOCHROME P450 (CYP) 1A2, CYP2A6, N-ACETYLTRANSFERASE AND XANTHINE OXIDASE ACTIVITY IN HEALTHY VOLUNTEERS
    Chen, Yao
    Xiao, Peng
    Ou-Yang, Dong-Sheng
    Fan, Lan
    Guo, Dong
    Wang, Yi-Nan
    Han, Yang
    Tu, Jiang-Hua
    Zhou, Gan
    Huang, Yuan-Fei
    Zhou, Hong-Hao
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2009, 36 (08) : 828 - 833
  • [40] Cytochrome P450 2C9-CYP2C9
    Van Booven, Derek
    Marsh, Sharon
    McLeod, Howard
    Carrillo, Michelle Whirl
    Sangkuhl, Katrin
    Klein, Teri E.
    Altman, Russ B.
    PHARMACOGENETICS AND GENOMICS, 2010, 20 (04): : 277 - 281